Kodiak Sciences Inc
KOD23.040USD
+2.030+9.66%
Cierre 02/06, 16:00（ET）Cotizaciones retrasadas 15 min
1.22BCap. mercado
PérdidaP/E TTM
Más Datos de Kodiak Sciences Inc Compañía
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab tedromer, is a novel anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer conjugate under development for the treatment of high prevalence retinal vascular diseases, including diabetic retinopathy and wet age-related macular degeneration. Its second investigational medicine, KSI-501, is a bispecific antibody biopolymer conjugate designed to inhibit interleukin-6 (IL-6)-mediated inflammation and VEGF. It is also developing a third investigational medicine, KSI-101, an unconjugated bispecific protein targeting IL-6 and VEGF.
Información de Kodiak Sciences Inc
Símbolo de cotizaciónKOD
Nombre de la empresaKodiak Sciences Inc
Fecha de salida a bolsaOct 04, 2018
Director ejecutivoPerlroth (Victor)
Número de empleados109
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 04
Dirección1250 Page Mill Rd
CiudadPALO ALTO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94304
Teléfono16502810850
Sitio Webhttps://kodiak.com/
Símbolo de cotizaciónKOD
Fecha de salida a bolsaOct 04, 2018
Director ejecutivoPerlroth (Victor)
Ejecutivos de Kodiak Sciences Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. John A. Borgeson
Mr. John A. Borgeson
Chief Financial Officer, Executive Vice President, Secretary
Chief Financial Officer, Executive Vice President, Secretary
183.32K
+1152.00%
Mr. Charles A. (Charlie) Bancroft
Mr. Charles A. (Charlie) Bancroft
Independent Director
Independent Director
25.95K
--
Mr. Robert A. Profusek, J.D.
Mr. Robert A. Profusek, J.D.
Lead Independent Director
Lead Independent Director
10.00K
--
Dr. Richard S. Levy, M.D.
Dr. Richard S. Levy, M.D.
Independent Director
Independent Director
1.00K
--
Dr. Victor Perlroth, M.D.
Dr. Victor Perlroth, M.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Felix J. Baker, Ph.D.
Dr. Felix J. Baker, Ph.D.
Independent Director
Independent Director
--
--
Dr. Bassil I. Dahiyat, Ph.D.
Dr. Bassil I. Dahiyat, Ph.D.
Independent Director
Independent Director
--
--
Dr. Taiyin Yang, Ph.D.
Dr. Taiyin Yang, Ph.D.
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. John A. Borgeson
Mr. John A. Borgeson
Chief Financial Officer, Executive Vice President, Secretary
Chief Financial Officer, Executive Vice President, Secretary
183.32K
+1152.00%
Mr. Charles A. (Charlie) Bancroft
Mr. Charles A. (Charlie) Bancroft
Independent Director
Independent Director
25.95K
--
Mr. Robert A. Profusek, J.D.
Mr. Robert A. Profusek, J.D.
Lead Independent Director
Lead Independent Director
10.00K
--
Dr. Richard S. Levy, M.D.
Dr. Richard S. Levy, M.D.
Independent Director
Independent Director
1.00K
--
Dr. Victor Perlroth, M.D.
Dr. Victor Perlroth, M.D.
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Felix J. Baker, Ph.D.
Dr. Felix J. Baker, Ph.D.
Independent Director
Independent Director
--
--
Desglose de ingresos
La empresa aún no ha revelado los datos relevantes.
La empresa aún no ha revelado los datos relevantes.
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.
Estadísticas de accionistas
Actualizado: dom., 8 de feb
Actualizado: dom., 8 de feb
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Baker Bros. Advisors LP
32.66%
Point72 Asset Management, L.P.
4.65%
Perlroth (Victor D)
4.42%
BlackRock Institutional Trust Company, N.A.
3.93%
The Vanguard Group, Inc.
3.79%
Otro
50.55%
Accionistas
Accionistas
Proporción
Baker Bros. Advisors LP
32.66%
Point72 Asset Management, L.P.
4.65%
Perlroth (Victor D)
4.42%
BlackRock Institutional Trust Company, N.A.
3.93%
The Vanguard Group, Inc.
3.79%
Otro
50.55%
Tipos de accionistas
Accionistas
Proporción
Hedge Fund
46.25%
Investment Advisor
19.99%
Investment Advisor/Hedge Fund
9.35%
Individual Investor
4.78%
Research Firm
1.78%
Endowment Fund
1.13%
Private Equity
1.04%
Pension Fund
0.17%
Sovereign Wealth Fund
0.08%
Otro
15.43%
Participación institucional
Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
262
48.78M
79.97%
+1.55M
2025Q3
248
41.93M
79.39%
-9.11M
2025Q2
273
46.04M
87.25%
-8.67M
2025Q1
302
46.32M
87.78%
-8.84M
2024Q4
308
44.88M
85.29%
-7.98M
2024Q3
318
42.74M
81.24%
-12.36M
2024Q2
326
43.49M
82.78%
-12.58M
2024Q1
345
46.64M
88.83%
-7.18M
2023Q4
377
44.39M
84.60%
-13.12M
2023Q3
391
45.97M
87.64%
-8.18M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Baker Bros. Advisors LP
19.92M
32.66%
+2.61M
+15.07%
Dec 18, 2025
Point72 Asset Management, L.P.
2.84M
4.65%
+2.38M
+526.72%
Sep 30, 2025
Perlroth (Victor D)
2.70M
4.42%
+527.00K
+24.31%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.40M
3.93%
-286.86K
-10.68%
Sep 30, 2025
The Vanguard Group, Inc.
1.95M
3.2%
+127.99K
+7.02%
Sep 30, 2025
Adage Capital Management, L.P.
1.33M
2.19%
-720.71K
-35.06%
Sep 30, 2025
ICONIQ Capital, LLC
1.27M
2.08%
--
--
Sep 30, 2025
TCG Crossover Management, LLC
1.15M
1.88%
--
--
Sep 30, 2025
SilverArc Capital Management, LLC
1.00M
1.64%
+598.46K
+149.04%
Sep 30, 2025
Acadian Asset Management LLC
969.91K
1.59%
-999.97K
-50.76%
Sep 30, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Fidelity Enhanced Small Cap ETF
0.18%
iShares Micro-Cap ETF
0.11%
Vanguard US Momentum Factor ETF
0.11%
Invesco RAFI US 1500 Small-Mid ETF
0.06%
iShares Health Innovation Active ETF
0.06%
iShares Russell 2000 Value ETF
0.05%
Invesco Russell 2000 Dynamic Multifactor ETF
0.05%
ProShares Hedge Replication ETF
0.03%
ProShares UltraPro Russell2000
0.03%
Proshares Ultra Russell 2000
0.02%
Ver más
Fidelity Enhanced Small Cap ETF
Proporción0.18%
iShares Micro-Cap ETF
Proporción0.11%
Vanguard US Momentum Factor ETF
Proporción0.11%
Invesco RAFI US 1500 Small-Mid ETF
Proporción0.06%
iShares Health Innovation Active ETF
Proporción0.06%
iShares Russell 2000 Value ETF
Proporción0.05%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporción0.05%
ProShares Hedge Replication ETF
Proporción0.03%
ProShares UltraPro Russell2000
Proporción0.03%
Proshares Ultra Russell 2000
Proporción0.02%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
